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Straining With the Ventricular
Assist Device and Right
Ventricular Function
We read with great interest the paper by Grant et al. (1) in which
they provide an analysis to support the use of strain imaging as a
unique echocardiographic measure to predict right ventricular
(RV) failure in patients undergoing left ventricular assist device
(LVAD) placement. In their study, the value of RV strain was
assessed using a multivariate logistic regression analysis and was
found, not only to be significant in predicting RV failure, but also toprovide incremental value to the Michigan RV risk score (2). The
clinical relevance of such a prediction tool is not trivial because survival
is significantly reduced in LVAD patients with ensuing RV failure.
The challenge for the practitioner is that the current VAD
landscape is riddled with prognostic scores that hope to improve our
clinical decision making at the time of patient evaluation for device
candidacy. As the authors point out, no fewer than 8 strategies have
been published specifically assessing the RV (2–9). This is in addition
to at least 6 predictive risk scoring systems used to assess outcomes for
pulsatile and continuous flow LVADs (10–15).
Strain measurements with echocardiography are derived prin-
cipally from the deformation of the myocardial wall. Intuitively,
patterns of RV strain should reflect loading conditions. It would
have been revealing to determine the relationship between RV
strain and right atrial pressure in their study population. Further-
more, the true clinical question may not be whether the patient will
develop right ventricular failure, but instead, should a biventricular
assist device be implanted. Including data on those patients who
received a biventricular assist device would have provided even
more valuable insights into the application of RV strain assessment
in clinical practice.
The added value of RV strain to the many predictive indices for
RV failure post-LVAD is promising, and as the authors suggest,
will need to be further evaluated in a prospective multicenter
manner. In the end, it may be that the quest for a precise RV
prediction score is doomed to failure due to unanticipated events in
the operating room. Significant bleeding requiring multiple blood
transfusions, RV ischemia, and even accidental mechanical damage
to the RV can contradict a clinical prediction model and render a
patient with good RV function to one destined for RV failure after
LVAD implantation.
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Reply
Weappreciate the interest ofDr. Thomas and colleagues in our work (1).
Our goal was not so much to produce a new score, but to
propose strain as a guide for the assessment of right ventricular
(RV) function. Evaluating the RV in these circumstances seems
like a rational step: the recognition of severe RV dysfunction might
reasonably lead the clinician to opt for a biventricular device in the
first instance. However, evaluation of the RV remains challenging,
and our observation is that strain, as a geometry-independenttechnique, avoids the limitations of the typical RV measures.
Perhaps because of this, it is more predictive of RV failure than
standard measures. However, as an ejection-phase marker, strain is
load dependent: in this population, the correlation between RV
strain and afterload (mean pulmonary artery pressure, r  0.16)
was greater than that with pre-load (right atrial pressure, r 0.03).
iven the elevation of both of these markers in almost all patients,
t is possible that the responses of RV strain to manipulations in
re-load, afterload, or contractility would add additional predictive
alue, but we did not test this.
There were 3 barriers to the study of elective biventricular
evices. First, insufficient numbers were available to address this
uestion, which probably requires a multicenter study to obtain
ufficient numbers of patients. Second, most of these patients were
n extracorporeal membrane oxygenation, which has a major
nfluence on attempted RV function measurement. Third, a study
esign to show the value of RV evaluation is difficult in patients
ith biventricular devices; certainly, the chosen endpoint has no
eaning in these patients.
The multiplicity of prognostic scores in the ventricular assist
evice literature is perhaps a reflection of the fact that some
pisodes of RV failure are due to bleeding, RV ischemia, and
ccidental mechanical damage to the RV, as Dr. Jorde et al.
ropose. These are unpredictable events that compromise the
erformance of any score. Notwithstanding the role of unpredict-
ble contributors, RV strain seems to be a useful factor when
onsidering the possible contributors to RV dysfunction in this
opulation.
ndrew D. M. Grant, MD
icholas G. Smedira, MD
andall C. Starling, MD, MPH








1. Grant AD, Smedira NG, Starling RC, Marwick TH. Independent and
incremental role of quantitative right ventricular evaluation for the
prediction of right ventricular failure after left ventricular assist device
implantation. J Am Coll Cardiol 2012;60:521–8.
